VYNE Therapeutics
Earnings Surprise
Analysts estimated VYNE earnings of $-0.18 per share this quarter (Q4). VYNE's actual earnings were $-0.11 per share.
VYNE EPS surprise of 38.50%Analysts estimated VYNE earnings of $-0.13 per share this quarter (Q3). VYNE's actual earnings were $-0.17 per share.
VYNE EPS surprise of -28.21%Analysts estimated VYNE earnings of $-0.23 per share this quarter (Q2). VYNE's actual earnings were $-0.13 per share.
VYNE EPS surprise of 42.93%Analysts estimated VYNE earnings of $-0.30 per share this quarter (Q1). VYNE's actual earnings were $-0.20 per share.
VYNE EPS surprise of 32.39%Analysts estimated VYNE earnings of $-0.31 per share this quarter (Q4). VYNE's actual earnings were $-0.28 per share.
VYNE EPS surprise of 9.50%Analysts estimated VYNE earnings of $-0.24 per share this quarter (Q3). VYNE's actual earnings were $-0.29 per share.
VYNE EPS surprise of -20.98%Analysts estimated VYNE earnings of $-0.19 per share this quarter (Q2). VYNE's actual earnings were $-0.22 per share.
VYNE EPS surprise of -13.52%Analysts estimated VYNE earnings of $-0.24 per share this quarter (Q1). VYNE's actual earnings were $-0.15 per share.
VYNE EPS surprise of 38.73%Analysts estimated VYNE earnings of $-0.51 per share this quarter (Q4). VYNE's actual earnings were $-0.20 per share.
VYNE EPS surprise of -60.78%Analysts estimated VYNE earnings of $-0.78 per share this quarter (Q3). VYNE's actual earnings were $-2.01 per share.
VYNE EPS surprise of 159.29%